Composition and method for combating macular degeneration

Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Heavy metal or compound thereof

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424630, 424639, 424641, 424702, 514251, 514345, 514458, 514474, 514494, 514562, 514912, A61K 3324, A61K 3334, A61K 3332, A61K 31525

Patent

active

051568527

ABSTRACT:
In accordance with the present invention, a composition is provided with Vitamins C and E, zinc acetate, copper, selenium, manganese, and at least one of L-cysteine, pyridoxine, and riboflavin. The Vitamins C and E serve as antioxidants, while the zinc acetate, copper, selenium and manganese serve as cofactors for metalloenzymes which scavenge oxidizers. The remaining three compounds tend to enhance glutathione concentration. All the elements are provided in a tablet or caplet form which is suitable for oral ingestion. Preferably, the composition is taken periodically each day of a treatment period.

REFERENCES:
patent: 4002758 (1977-01-01), Bigou
patent: 5075116 (1991-12-01), La Haye et al.
Machlin, Lawrence J., et al., FASEB J., 1: 441-445 (1987) "Free Radical Tissue Damage: Protective Role of Antioxidant Nutrients".

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Composition and method for combating macular degeneration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition and method for combating macular degeneration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method for combating macular degeneration will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-190681

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.